Business Ethics, Corporate Social Responsibility Drug Industry Lobbyists and Campaign Cash Stymie Bid to Restrain Medicare Prescription Costs Score 0%
Business Ethics, Regulation & Legislation Drug Companies Pay Up in Illegal Marketing Cases, But Are Penalties Enough? Score 0%
Business Ethics, Regulation & Legislation Vying for Market Share, Companies Heavily Promote ‘Me Too’ Drugs Score 0%
Corporate Social Responsibility, Economy & Society, Environmental Sustainability, Sustainable Investing Sustainability Reporting Group Issues First Standards for SEC Filings Score 0%
Business Ethics, Governance & Compliance, Regulation & Legislation Pfizer’s Latest Twist on ‘Pay for Delay’ Score 0%
Business Ethics, Governance & Compliance, Regulation & Legislation Doctors Avoid Penalties in Suits Against Medical Firms Score 0%
Corporate Social Responsibility, Sustainable Investing Investors Press Companies on U.S. Chamber Board Roles Score 0%
Corporate Social Responsibility, Governance & Compliance, Regulation & Legislation, Sustainable Investing Opinion: U.S. Chamber of Commerce and A Failure in Governance Score 0%
Business Ethics, Governance & Compliance, Regulation & Legislation Docs on Pharma Payroll Have Blemished Records Score 0%
Business Ethics, Governance & Compliance, Regulation & Legislation Lawsuits Say Pharma Illegally Paid Doctors to Push Their Drugs Score 0%
Business Ethics, Corporate Social Responsibility, Environmental Sustainability, Governance & Compliance, Sustainable Investing Verbatim: How Businesses View Sustainability & CSR Reporting Score 0%
